IP Library Patent Application 18983019
Patent Application
App. No. 18/983,019

DNA Polymerases and Related Methods

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/983,019
Abstract

Provided herein is an engineered DNA polymerases containing an amino acid sequence selected from: an amino acid sequence that is at least 80% identical to an amino acid sequence selected from: SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, and SEQ ID NO:24; and an amino acid sequence that is at least 92% identical to an amino acid sequence selected from: SEQ ID NO:2 and SEQ ID NO:3. Also provided are methods employing the described DNA polymerases.

Claims (31)

1 . A DNA polymerase comprising an amino acid sequence selected from:

an amino acid sequence that is at least 80% identical to an amino acid sequence selected from: SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, and SEQ ID NO:24; and

an amino acid sequence that is at least 92% identical to an amino acid sequence selected from: SEQ ID NO:2 and SEQ ID NO:3.

2 . The DNA polymerase of claim 1 , comprising an amino acid sequence that is at least 90% identical to an amino acid sequence selected from: SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, and SEQ ID NO:24.

3 . The DNA polymerase of claim 1 , comprising an amino acid sequence that is at least 95% identical to an amino acid sequence selected from: SEQ ID NO: 2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, and SEQ ID NO:24.

4 . The DNA polymerase of claim 1 , comprising an amino acid sequence that is identical to an amino acid sequence selected from: SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5 SEQ ID NO:6, and SEQ ID NO:24.

5 . A DNA polymerase, wherein the DNA polymerase is a fusion protein comprising an amino acid sequence of claim 1 and an exogenous amino acid sequence.

6 . The DNA polymerase of claim 5 , wherein the exogenous amino acid sequence comprises a DNA binding domain.

7 . The DNA polymerase of claim 5 , wherein the exogenous amino acid sequence comprises a purification tag.

8 . A method, comprising:

incubating a reaction mixture comprising:

(i) a DNA polymerase of claim 1 ;

(ii) a target nucleic acid;

(iii) dNTPs; and

(iv) one or more primers,

under conditions suitable for polynucleotide extension of the target nucleic acid to produce a copy of the target nucleic acid.

9 . The method of claim 8 , wherein the conditions are isothermal.

10 . The method of claim 9 , wherein the one or more primers comprise Loop-Mediated Isothermal Amplification (LAMP) primers.

11 . A composition comprising: (i) an aqueous solution of or (ii) a freeze-dried/lyophilized form of the DNA polymerase of claim 1 .

12 . The composition of claim 11 , wherein the DNA polymerase is in a solution that comprises glycerol.

13 . The composition of claim 11 , further comprising a solid support.

14 . The composition of claim 11 , further comprising one or more components selected from a buffering agent, a salt, a primer, and an aptamer.

15 . A kit comprising:

a DNA polymerase of claim 1 ; and

a reaction buffer.

16 . The kit of claim 15 , further comprising dNTPs.

17 . The kit of claim 15 , wherein the DNA polymerase is in a form selected from: dried form, lyophilized form, solution form.

18 . The kit of claim 15 , wherein the reaction buffer comprises a buffering agent and a salt.

19 . The kit of claim 15 , wherein the DNA polymerase is provided in a separate tube from reaction buffer.

20 . The kit of claim 15 , wherein the reaction mixture is suitable for receiving and extending a target nucleic acid in the presence of the DNA polymerase and one or more primers.

21 . The kit of claim 15 , further comprising one or more additional enzymes, optionally selected from a reverse transcriptase and a uracil DNA glycosidase (UDG).

Assignments (2)
SECURITY INTEREST Recorded May 29, 2026
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 074795/0566 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2025
From: CROSBY, HEIDI; MINSKY, BURCU BAYKAL; ONG, JENNIFER; PATTON, GREGORY; TANNER, NATHAN; MA, DONG; JOHNSON, SEAN R.; GRAY, ANDREW
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 069799/0194 →